Skip to content
The Nexus
BUSINESSAug 11 · 11:38 UTCWTOP DCWTOP Staff

Neurogene: Q2 Earnings Snapshot

Neurogene Inc. reported a loss of $34.5 million and a loss of $1.53 per share for its second quarter. These results missed Wall Street expectations, as the average estimate from four analysts surveyed by Zacks Investment Research was a loss of $1.40 per share.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Neurogene Inc.organizationNGNEtopicNew YorkplaceAPorganizationZacks Investment ResearchorganizationAutomated Insightsorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting